Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses

Neuron

Volumn 81, Issue 5, 2014, Pages 1111-1125

  Ramikie, Teniel S ^a   Nyilas, Rita ^b   Bluett, Rebecca J ^a   Gamble George, Joyonna C ^a   Hartley, Nolan D ^a   Mackie, Ken ^c   Watanabe, Masahiko ^d   Katona, István ^b   Patel, Sachin ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c INDIANA UNIVERSITY   (United States)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMIC ACID; MESSENGER RNA; CHOLINERGIC RECEPTOR;

ARTICLE; BASOLATERAL AMYGDALA; CB1 GENE; CELLULAR DISTRIBUTION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; CORPUS STRIATUM; EMOTIONALITY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; GLUTAMATERGIC SYNAPSE; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SYNAPSE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; BRAIN NERVE CELL; CELLULAR SECRETION; CELLULAR STRESS RESPONSE; GABAERGIC TRANSMISSION; INTRACELLULAR SIGNALING; LEARNING; MALE; MOUSE; NERVE CELL STIMULATION; NONHUMAN; POSTSYNAPTIC MEMBRANE;

AMYGDALA; ANIMALS; CALCIUM; ENDOCANNABINOIDS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; MALE; MICE; MICE, INBRED ICR; NEURONS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84895425510     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.01.012     Document Type: Article

References (68)

1. Amano T., Unal C.T., Paré D. Synaptic correlates of fear extinction in the amygdala. Nat. Neurosci. 2010, 13:489-494.
2. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Ann. N Y Acad. Sci. 1999, 877:217-241.
3. Castillo P.E., Younts T.J., Chávez A.E., Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron 2012, 76:70-81.
4. Chávez A.E., Chiu C.Q., Castillo P.E. TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat. Neurosci. 2010, 13:1511-1518.
5. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., Ehrlich I., Sprengel R., Deisseroth K., Stadler M.B., et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468:277-282.
6. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 2001, 98:9371-9376.
7. Davis M. Neurobiology of fear responses: the role of the amygdala. J. Neuropsychiatry Clin. Neurosci. 1997, 9:382-402.
8. Delaney A.J., Crane J.W., Sah P. Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism. Neuron 2007, 56:880-892.
9. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 2002, 99:10819-10824.
10. Dong Y.L., Fukazawa Y., Wang W., Kamasawa N., Shigemoto R. Differential postsynaptic compartments in the laterocapsular division of the central nucleus of amygdala for afferents from the parabrachial nucleus and the basolateral nucleus in the rat. J. Comp. Neurol. 2010, 518:4771-4791.
11. Edwards D.A., Kim J., Alger B.E. Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 2006, 95:67-75.
12. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Lüthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
13. El-Amamy H., Holland P.C. Dissociable effects of disconnecting amygdala central nucleus from the ventral tegmental area or substantia nigra on learned orienting and incentive motivation. Eur. J. Neurosci. 2007, 25:1557-1567.
14. Groshek F., Kerfoot E., McKenna V., Polackwich A.S., Gallagher M., Holland P.C. Amygdala central nucleus function is necessary for learning, but not expression, of conditioned auditory orienting. Behav. Neurosci. 2005, 119:202-212.
15. Grueter B.A., Brasnjo G., Malenka R.C. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat. Neurosci. 2010, 13:1519-1525.
16. Hanus L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., Mechoulam R. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA 2001, 98:3662-3665.
17. Hashimotodani Y., Ohno-Shosaku T., Tsubokawa H., Ogata H., Emoto K., Maejima T., Araishi K., Shin H.S., Kano M. Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
18. Hashimotodani Y., Ohno-Shosaku T., Kano M. Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr. Opin. Neurobiol. 2007, 17:360-365.
19. Hashimotodani Y., Ohno-Shosaku T., Tanimura A., Kita Y., Sano Y., Shimizu T., Di Marzo V., Kano M. Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: evidence for on-demand biosynthesis of 2-arachidonoylglycerol. J. Physiol. 2013, 591:4765-4776.
20. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., Biag J., Dong H.W., Deisseroth K., Callaway E.M., et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468:270-276.
21. Hill M.N., Hillard C.J., Bambico F.R., Patel S., Gorzalka B.B., Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol. Sci. 2009, 30:484-493.
22. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J. Neurosci. 2010, 30:14980-14986.
23. Huang G.Z., Woolley C.S. Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron 2012, 74:801-808.
24. Hudson B.D., Hébert T.E., Kelly M.E. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor. Mol. Pharmacol. 2010, 77:1-9.
25. Kamprath K., Romo-Parra H., Häring M., Gaburro S., Doengi M., Lutz B., Pape H.C. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 2011, 36:652-663.
26. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
27. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 2012, 35:529-558.
28. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 2001, 21:9506-9518.
29. Katona I., Urbán G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 2006, 26:5628-5637.
30. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat. Neurosci. 2010, 13:592-600.
31. Kim J., Isokawa M., Ledent C., Alger B.E. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci. 2002, 22:10182-10191.
32. Lau B.K., Vaughan C.W. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Mol. Pharmacol. 2008, 74:1392-1398.
33. Lerner T.N., Kreitzer A.C. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron 2012, 73:347-359.
34. Li S., Kirouac G.J. Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J. Comp. Neurol. 2008, 506:263-287.
35. Li H., Penzo M.A., Taniguchi H., Kopec C.D., Huang Z.J., Li B. Experience-dependent modification of a central amygdala fear circuit. Nat. Neurosci. 2013, 16:332-339.
36. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., Pavón F.J., Serrano A.M., Selley D.E., Parsons L.H., et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 2009, 5:37-44.
37. Ludányi A., Hu S.S., Yamazaki M., Tanimura A., Piomelli D., Watanabe M., Kano M., Sakimura K., Maglóczky Z., Mackie K., et al. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 2011, 174:50-63.
38. Lutz B. The endocannabinoid system and extinction learning. Mol. Neurobiol. 2007, 36:92-101.
39. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agrò A., et al. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 2008, 11:152-159.
40. Mangoura D., Sogos V., Pelletiere C., Dawson G. Differential regulation of phospholipases C and D by phorbol esters and the physiological activators carbachol and glutamate in astrocytes from chicken embryo cerebrum and cerebellum. Brain Res. Dev. Brain Res. 1995, 87:12-21.
41. Mathur B.N., Tanahira C., Tamamaki N., Lovinger D.M. Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity. Nat. Neurosci. 2013, 16:1275-1283.
42. McDonald A.J. Cytoarchitecture of the central amygdaloid nucleus of the rat. J. Comp. Neurol. 1982, 208:401-418.
43. McDonald A.J., Shammah-Lagnado S.J., Shi C., Davis M. Cortical afferents to the extended amygdala. Ann. N Y Acad. Sci. 1999, 877:309-338.
44. McKenzie F.R., Seuwen K., Pouysségur J. Stimulation of phosphatidylcholine breakdown by thrombin and carbachol but not by tyrosine kinase receptor ligands in cells transfected with M1 muscarinic receptors. Rapid desensitization of phosphocholine-specific (PC) phospholipase D but sustained activity of PC-phospholipase C. J. Biol. Chem. 1992, 267:22759-22769.
45. Narushima M., Hashimoto K., Kano M. Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum. Neurosci. Res. 2006, 54:159-164.
46. Ohno-Shosaku T., Hashimotodani Y., Maejima T., Kano M. Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium. Cell Calcium 2005, 38:369-374.
47. Ohno-Shosaku T., Tanimura A., Hashimotodani Y., Kano M. Endocannabinoids and retrograde modulation of synaptic transmission. Neuroscientist 2012, 18:119-132.
48. Pan B., Wang W., Zhong P., Blankman J.L., Cravatt B.F., Liu Q.S. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J. Neurosci. 2011, 31:13420-13430.
49. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol. Rev. 2010, 90:419-463.
50. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J. Pharmacol. Exp. Ther. 2006, 318:304-311.
51. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
52. Péterfi Z., Urbán G.M., Papp O.I., Németh B., Monyer H., Szabó G., Erdélyi F., Mackie K., Freund T.F., Hájos N., Katona I. Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. J. Neurosci. 2012, 32:14448-14463.
53. Puente N., Cui Y., Lassalle O., Lafourcade M., Georges F., Venance L., Grandes P., Manzoni O.J. Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci. 2011, 14:1542-1547.
54. Ramikie T.S., Patel S. Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress. Neuroscience 2012, 204:38-52.
55. Riebe C.J., Pamplona F.A., Kamprath K., Wotjak C.T. Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it. Neuroscience 2012, 204:159-185.
56. Roberto M., Cruz M., Bajo M., Siggins G.R., Parsons L.H., Schweitzer P. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 2010, 35:1962-1972.
57. Roozendaal B., van der Zee E.A., Hensbroek R.A., Maat H., Luiten P.G., Koolhaas J.M., Bohus B. Muscarinic acetylcholine receptor immunoreactivity in the amygdala-II. Fear-induced plasticity. Neuroscience 1997, 76:75-83.
58. Schmidt M., Fasselt B., Rümenapp U., Bienek C., Wieland T., van Koppen C.J., Jakobs K.H. Rapid and persistent desensitization of m3 muscarinic acetylcholine receptor-stimulated phospholipase D. Concomitant sensitization of phospholipase C. J. Biol. Chem. 1995, 270:19949-19956.
59. Straiker A., Mackie K. Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J. Physiol. 2007, 578:773-785.
60. Sumislawski J.J., Ramikie T.S., Patel S. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 2011, 36:2750-2761.
61. Sun N., Yi H., Cassell M.D. Evidence for a GABAergic interface between cortical afferents and brainstem projection neurons in the rat central extended amygdala. J. Comp. Neurol. 1994, 340:43-64.
62. Tanimura A., Yamazaki M., Hashimotodani Y., Uchigashima M., Kawata S., Abe M., Kita Y., Hashimoto K., Shimizu T., Watanabe M., et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 2010, 65:320-327.
63. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., Thompson K.R., Gradinaru V., Ramakrishnan C., Deisseroth K. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362.
64. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 2007, 27:3663-3676.
65. van der Zee E.A., Roozendaal B., Bohus B., Koolhaas J.M., Luiten P.G. Muscarinic acetylcholine receptor immunoreactivity in the amygdala-I. Cellular distribution correlated with fear-induced behavior. Neuroscience 1997, 76:63-73.
66. Wang D.J., Yang D., Su L.D., Xie Y.J., Zhou L., Sun C.L., Wang Y., Wang X.X., Zhou L., Shen Y. Cytosolic phospholipase A2 alpha/arachidonic acid signaling mediates depolarization-induced suppression of excitation in the cerebellum. PLoS ONE 2012, 7:e41499.
67. Yoshida T., Uchigashima M., Yamasaki M., Katona I., Yamazaki M., Sakimura K., Kano M., Yoshioka M., Watanabe M. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc. Natl. Acad. Sci. USA 2011, 108:3059-3064.
68. Zhang L., Wang M., Bisogno T., Di Marzo V., Alger B.E. Endocannabinoids generated by Ca2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase. PLoS ONE 2011, 6:e16305.